Propanc Biopharma, Inc. SEC filings PPCB
Propanc Biopharma, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jun 23, 2011. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 27, 2026 | — |
| EFFECT | Filing | Apr 20, 2026 | — |
| CORRESP | Letter to the SEC | Apr 16, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2026 | — |
| EFFECT | Filing | Feb 24, 2026 | — |
| CORRESP | Letter to the SEC | Feb 20, 2026 | — |
| CORRESP | Letter to the SEC | Feb 12, 2026 | — |
| CORRESP | Letter to the SEC | Feb 10, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2026 | — |
| EFFECT | Filing | Jan 9, 2026 | — |
| CORRESP | Letter to the SEC | Jan 6, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| CERT | Filing | Aug 14, 2025 | — |
| EFFECT | Filing | Aug 13, 2025 | — |
| 8-A12B | Filing | Aug 13, 2025 | — |
| CORRESP | Letter to the SEC | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| CORRESP | Letter to the SEC | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2024 | — |
| NT 10-Q | Filing | Feb 14, 2024 | Dec 31, 2023 |
| D | Filing | Nov 3, 2023 | — |
| D | Filing | Oct 26, 2023 | — |
| EFFECT | Filing | Oct 12, 2023 | — |
| CORRESP | Letter to the SEC | Oct 10, 2023 | — |
| D | Filing | Aug 31, 2023 | — |
| D | Filing | Aug 31, 2023 | — |
| D | Filing | Aug 30, 2023 | — |
| D | Filing | Aug 16, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2023 | — |
| D | Filing | Aug 15, 2023 | — |
| EFFECT | Filing | Mar 27, 2023 | — |
| EFFECT | Filing | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 10, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2022 | — |
| EFFECT | Filing | Jan 14, 2022 | — |
| EFFECT | Filing | Nov 12, 2020 | — |
| CORRESP | Letter to the SEC | Nov 10, 2020 | — |
| CORRESP | Letter to the SEC | Nov 3, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2020 | — |
| NT 10-K | Filing | Sep 29, 2020 | Jun 30, 2020 |
| CORRESP | Letter to the SEC | Aug 13, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2020 | — |
| CORRESP | Letter to the SEC | Jul 22, 2020 | — |
| PRER14C | Filing | Jul 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2020 | — |
| PRER14C | Filing | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jun 26, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2020 | — |
| UPLOAD | Letter from the SEC | May 28, 2020 | — |
| D | Filing | Apr 17, 2020 | — |
| EFFECT | Filing | Feb 14, 2020 | — |
| CORRESP | Letter to the SEC | Feb 11, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2019 | — |
| NT 10-K | Filing | Sep 30, 2019 | Jun 30, 2019 |
| RW | Filing | Aug 21, 2019 | — |
| RW WD | Filing | Aug 20, 2019 | — |
| RW | Filing | Aug 19, 2019 | — |
| EFFECT | Filing | Jun 21, 2019 | — |
| CORRESP | Letter to the SEC | Jun 20, 2019 | — |
| UPLOAD | Letter from the SEC | May 29, 2019 | — |
| EFFECT | Filing | Mar 7, 2019 | — |
| CORRESP | Letter to the SEC | Mar 5, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2019 | — |
| D | Filing | Jan 2, 2019 | — |
| D | Filing | Jan 2, 2019 | — |
| EFFECT | Filing | Oct 30, 2018 | — |
| CORRESP | Letter to the SEC | Oct 26, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2018 | — |
| D | Filing | Oct 11, 2018 | — |
| D | Filing | Oct 1, 2018 | — |
| D | Filing | Sep 17, 2018 | — |
| RW | Filing | Dec 12, 2016 | — |
| EFFECT | Filing | Oct 18, 2016 | — |
| EFFECT | Filing | Oct 18, 2016 | — |
| EFFECT | Filing | Apr 18, 2016 | — |
| CORRESP | Letter to the SEC | Apr 14, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2016 | — |
| EFFECT | Filing | Dec 10, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2015 | — |
| CORRESP | Letter to the SEC | Dec 4, 2015 | — |
| NT 10-K | Filing | Sep 29, 2015 | Jun 30, 2015 |
| NT 10-Q | Form nt 10-q | Nov 14, 2014 | Sep 30, 2014 |
| NT 10-K | Form nt 10-k | Sep 29, 2014 | Jun 30, 2014 |
| NT 10-Q | Late filing notification | May 13, 2014 | Mar 31, 2014 |
| NT 10-K | Late filing notice | Sep 26, 2013 | Jun 30, 2013 |
| NT 10-Q | Notice of late filing | May 15, 2013 | Mar 31, 2013 |
| D | Filing | May 8, 2013 | — |
| NT 10-Q | Late filing notice | Feb 14, 2013 | Dec 31, 2012 |
| 8-A12G | Registration | Jan 11, 2013 | — |
| EFFECT | Filing | Jan 10, 2013 | — |
| CORRESP | Letter to the SEC | Jan 8, 2013 | — |
| CORRESP | Letter to the SEC | Jan 7, 2013 | — |
| NT 10-Q | Notification of late filing | Nov 13, 2012 | Sep 30, 2012 |
| NT 10-K | Late filing notice | Sep 27, 2012 | Jun 30, 2012 |
| D | Filing | Jun 4, 2012 | — |
| NT 10-Q | Notification of late filing | May 15, 2012 | Mar 31, 2012 |
| EFFECT | Filing | Apr 13, 2012 | — |
| NT 10-Q | Notification of late filing | Feb 14, 2012 | Dec 31, 2011 |
| EFFECT | Filing | Dec 15, 2011 | — |
| CORRESP | Letter to the SEC | Dec 13, 2011 | — |
| CORRESP | Letter to the SEC | Dec 7, 2011 | — |
| CORRESP | Letter to the SEC | Nov 14, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2011 | — |
| CORRESP | Letter to the SEC | Oct 27, 2011 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2011 | — |
| CORRESP | Letter to the SEC | Sep 30, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2011 | — |
| CORRESP | Letter to the SEC | Aug 23, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2011 | — |
| CORRESP | Letter to the SEC | Aug 18, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2011 | — |
Showing 120 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPCB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Camberwell, Victoria, Australia
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1517681
- Former names
- Propanc Health Group Corp (until Apr 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.